The price list of the targeted drug trametinib has been announced

Trametinib's benefits outweigh its risks in cancers carrying the BRAF V600 mutation. When used alone or in combination with dabrafenib, trametinib has shown clinically relevant benefit in patients with non-small cell lung cancer or melanoma that has spread or is unresectable, and has benefit in patients with advanced melanoma that has been surgically removed. With appropriate measures, the side effects of trametinib are considered acceptable and manageable.

The original drug of Trametinib has been launched in China and is sold under the name of Trametinib Tablets/Megenin, and has been included in the reimbursement scope of Class B medical insurance, but it may only be selected by patients who meet the indications. Trametinib is a prescription drug, and patients must have a doctor's prescription to purchase the drug. The common specification of 2mg*30 tablets is more than 10,000 yuan, and the price of 0.5mg*30 tablets is more than 5,000 yuan. The price is relatively expensive. As for the original trametinib drug sold overseas, the price of the Turkish version of 2mg*30 tablets is more than 7,000 yuan (the price may fluctuate due to exchange rates).

Currently, there are also generic trametinib drugs produced overseas in other countries. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. Common manufacturers of generic drugs include Laos Second Pharmaceutical Factory, Lucius Pharmaceuticals, etc. Common generic drug specificationsThe price of 2mg*30 tablets is more than 2,000 yuan (the price may fluctuate due to the exchange rate), which is much lower than the price of the original drug. For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.